Life Technologies | Spese Operative



Operating Expenses Cambiamento Data
Ardelyx USD 108M 12M 2024-12
Biogen USD 2.01B 13.3M 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Cipla INR 53.64B 164.8M 2024-12
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 12.64M 2.52M 2024-09
CSL USD 5.55B 108M 2024-06
Galapagos EUR 138.22M 24.07M 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
Grifols EUR 1.6B 128.03M 2024-12
Life Technologies USD 18.14M 828K 2024-09
Novartis USD 11.28B 1.73B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
United Therapeutics USD 378.2M 27.6M 2024-12



Life Technologies Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.